Medicines and Healthcare products Regulatory Agency
The agency will be piloting a public session at its board meeting in February.
The public session will be held in the morning before a private session in the afternoon. By necessity, discussion of policy matters in development, commercial or staff confidentiality, product or safety issues, forthcoming announcements or publications will be taken in private session.
Details
The first pilot meeting in public session will take place on:
12 February 2016, 10:00am to 12:00pm
151 Buckingham Palace Road
London
SW1W 9SZ
A second meeting in public session will take place later in the year.
There is space for 10 members of the public to attend the public session of the open board meeting. Registration will be on a first come, first served basis.
See the draft agenda for information about the session and register your interest via email to directorate@mhra.gsi.gov.uk if you are a general member of the public. Media representatives should contact the News Centre on 020 3080 7651 or email newscentre@mhra.gsi.gov.uk.
Members of the public will have an opportunity to ask questions at the end of each discussion item at the discretion of the Chair.